Content » Vol 98, Issue 9

Editorial

Changes in Editorial Board of Acta Dermato-Venereologica

Artur Schmidtchen and Anders Vahlquist

Two distinguished members of the editorial board of ActaDV, Dr Lisa Naysmith and Professor Marcel Jonkman, recently announced that they wished to step down as Sections Editors after many years of excellent service to the journal. We are very grateful for their expert help with submitted papers related to skin tumours & surgery and bullous & genetic disorders of the skin, respectively.

We would also like to welcome two new Section Editors: Professor Elisabet Nylander in the area of Venereology and STI and Professor Jürg Hafner in the area of Skin cancer, Skin tumours, and Melanoma.

Elisabet Nylander is Professor of Dermatology and Venereology at the Department of Public Health and Clinical Medicine at Umeå University, Sweden. She did her basic training in Medicine at Umeå University in the northern part of Sweden (MD 1980), became a specialist in Dermatology and Venereology in 1988, PhD 1997. Her main clinical work has been focused on vulvar diseases, establishing the first vulvar clinic in Sweden, and venereology. The main research projects have been on risk factors for acquiring an STI and on vulvar diseases, mainly erosive lichen planus. The work also includes teaching and supervision of PhD-students.

Jürg Hafner is Professor at the Department of Dermatology at the Medical Faculty, University of Zurich,  University Hospital of Zurich, Switzerland. He did his basic training at the University of Zurich, and became a specialist in Dermatology and Venereolog in 1994, Associate professor 2001, and Full professor 2008. He has published over 100 research articles, and the main clinical interest has been focused on dermatologic surgery including Mohs surgery, as well as angiology and wound healing. He holds several positions as Board member, including the Swiss Institute of Medical Education, International Society of Dermatologic Surgery, and is also secretary of the Swiss Society of Phlebology.

We welcome both these new collaborators and appreciate their help improving ActaDV further.